RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for TCR2 Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for TCR2 Therapeutics Inc. is TCRR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell TCR2 Therapeutics Inc. Stock?
TCR2 Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy TCR2 Therapeutics Inc. Stock?
TCR2 Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy TCR2 Therapeutics Inc. Stock.

What's the current price of TCR2 Therapeutics Inc. Stock?
As of the end of day on the 2023-08-30, the price of an TCR2 Therapeutics Inc. (TCRR) share was $1.48.

What is the 52-week high and low for TCR2 Therapeutics Inc. Stock?
The 52-week high for TCR2 Therapeutics Inc. Stock is $3.03 and the 52-week low is $0.82.

What is the market capitalization of TCR2 Therapeutics Inc. Stock?
As of the 2023-08-30, the market capitalization of TCR2 Therapeutics Inc. is 58.107M.
Click to get the best stock tips daily for free!

About TCR2 Therapeutics Inc.

TCR2 Therapeutics. TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical trial for the treatment of non-small cell lung cancer (NSCLC), ovarian cancer, malignant pleural/peritoneal... TCRR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT